These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8261756

  • 1. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry.
    Vora JP, Burch A, Peters JR, Owens DR.
    Diabet Med; 1993 Oct; 10(8):736-43. PubMed ID: 8261756
    [Abstract] [Full Text] [Related]

  • 2. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.
    Vora JP, Burch A, Peters JR, Owens DR.
    Diabetes Care; 1992 Nov; 15(11):1484-93. PubMed ID: 1334825
    [Abstract] [Full Text] [Related]

  • 3. Intraregional differences in the absorption of unmodified insulin from the abdominal wall.
    Frid A, Linde B.
    Diabet Med; 1992 Apr; 9(3):236-9. PubMed ID: 1533580
    [Abstract] [Full Text] [Related]

  • 4. Absorption of rapid-acting insulin in obese and nonobese NIDDM patients.
    Clauson PG, Linde B.
    Diabetes Care; 1995 Jul; 18(7):986-91. PubMed ID: 7555561
    [Abstract] [Full Text] [Related]

  • 5. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E, Gunnarsson R, Linde B.
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [Abstract] [Full Text] [Related]

  • 6. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P.
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [Abstract] [Full Text] [Related]

  • 7. Skinfold thickness, local subcutaneous blood flow and insulin absorption in diabetic patients.
    Hildebrandt P.
    Acta Physiol Scand Suppl; 1991 Aug; 603():41-5. PubMed ID: 1789128
    [Abstract] [Full Text] [Related]

  • 8. Relationship between subcutaneous blood flow and absorption of lente type insulin.
    Hildebrant P, Mehlsen J, Birch K, Kühl C.
    Diabetes Res; 1987 Apr; 4(4):179-81. PubMed ID: 3621801
    [Abstract] [Full Text] [Related]

  • 9. Clinically important differences in insulin absorption from abdomen in IDDM.
    Frid A, Linde B.
    Diabetes Res Clin Pract; 1993 Apr; 21(2-3):137-41. PubMed ID: 8269814
    [Abstract] [Full Text] [Related]

  • 10. Basal rate subcutaneous insulin infusion: absorption kinetics and relation to local blood flow.
    Hildebrandt P, Birch K.
    Diabet Med; 1988 Apr; 5(5):434-40. PubMed ID: 2970915
    [Abstract] [Full Text] [Related]

  • 11. Orthostatic changes in subcutaneous blood flow and insulin absorption.
    Hildebrandt P, Birch K, Sestoft L, Nielsen SL.
    Diabetes Res; 1985 Jul; 2(4):187-90. PubMed ID: 3910326
    [Abstract] [Full Text] [Related]

  • 12. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S, Vaag A, Langkjaer L, Hougaard P, Markussen J.
    BMJ; 1989 Aug 12; 299(6696):415-9. PubMed ID: 2506998
    [Abstract] [Full Text] [Related]

  • 13. Influence of aprotinin on insulin absorption and subcutaneous blood flow in type 1 (insulin-dependent) diabetes.
    Linde B, Gunnarsson R.
    Diabetologia; 1985 Sep 12; 28(9):645-8. PubMed ID: 2415419
    [Abstract] [Full Text] [Related]

  • 14. Effects of accidental intramuscular injection on insulin absorption in IDDM.
    Frid A, Gunnarsson R, Güntner P, Linde B.
    Diabetes Care; 1988 Jan 12; 11(1):41-5. PubMed ID: 3276476
    [Abstract] [Full Text] [Related]

  • 15. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP, Owens DR, Dolben J, Atiea JA, Dean JD, Kang S, Burch A, Brange J.
    BMJ; 1988 Nov 12; 297(6658):1236-9. PubMed ID: 3145064
    [Abstract] [Full Text] [Related]

  • 16. The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration.
    Hildebrandt P, Sestoft L, Nielsen SL.
    Diabetes Care; 1983 Nov 12; 6(5):459-62. PubMed ID: 6400706
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S, Brange J, Burch A, Vølund A, Owens DR.
    Diabetes Care; 1991 Nov 12; 14(11):942-8. PubMed ID: 1797506
    [Abstract] [Full Text] [Related]

  • 18. Insulin absorption, glucose homeostasis, and lipolysis in IDDM during mental stress.
    Fernqvist-Forbes E, Linde B.
    Diabetes Care; 1991 Nov 12; 14(11):1006-12. PubMed ID: 1797480
    [Abstract] [Full Text] [Related]

  • 19. The influence of aprotinin on regional absorption of soluble human insulin.
    Owens DR, Vora JP, Birtwell J, Luzio S, Hayes TM.
    Br J Clin Pharmacol; 1988 Apr 12; 25(4):453-6. PubMed ID: 2454647
    [Abstract] [Full Text] [Related]

  • 20. Unchanged insulin absorption after 4 days' use of subcutaneous indwelling catheters for insulin injections.
    Hanas SR, Carlsson S, Frid A, Ludvigsson J.
    Diabetes Care; 1997 Apr 12; 20(4):487-90. PubMed ID: 9096966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.